Literature DB >> 28587383

Mechanism of the protective effects of the combined treatment with rhynchophylla total alkaloids and sinapine thiocyanate against a prothrombotic state caused by vascular endothelial cell inflammatory damage.

Yunlun Li1, Xinya Zhang2, Wenqing Yang2, Chao Li2, Yanjun Chu2, Haiqiang Jiang2, Zhenzhen Shen2.   

Abstract

The aim of the present study was to investigate the effect and the underlying mechanism of the combined treatment of rhynchophylla total alkaloids (RTA) and sinapine thiocyanate for protection against a prothrombotic state (PTS) associated with the tumor necrosis factor-alpha (TNF-α)-induced inflammatory injury of vascular endothelial cells (VECs). A TNF-α-induced VEC inflammatory injury model was established, and cell morphology of VECs was evaluated using scanning electron microscopy. In addition, reverse transcription-quantitative polymerase chain reaction and western blot analysis were performed to examine the mRNA and protein expression of coagulation-related factors, including nuclear factor-κB (NF-κB), transforming growth factor-β1 (TGF-β1), tissue factor (TF), plasminogen activator inhibitor (PAI-1), protease-activation receptors (PAR-1) and protein kinase C (PKC-α) in VECs. Combined treatment with RTA and sinapine thiocyanate was demonstrated to reduce, to a varying extent, the mRNA and protein expression of NF-κB, TGF-β1, TF, PAR-1, PKC-α and PAI-1. Furthermore, combined treatment with RTA and sinapine thiocyanate was able to downregulate the expression of coagulation-related factors in injured VECs, thereby inhibiting the PTS induced by vascular endothelial injury. The underlying mechanism is partially associated with the TF-mediated activation of the thrombin-receptor signaling pathway that suppresses coagulation during inflammation and balances fibrinolysis in order to inhibit fibrin generation and deposition.

Entities:  

Keywords:  inflammatory damage; prothrombotic state; rhynchophylla total alkaloids; sinapine thiocyanate; vascular endothelial cells

Year:  2017        PMID: 28587383      PMCID: PMC5450770          DOI: 10.3892/etm.2017.4357

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  25 in total

1.  Target organ damage and the prothrombotic state in hypertension.

Authors:  G Y Lip
Journal:  Hypertension       Date:  2000-12       Impact factor: 10.190

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Adenovirus-mediated overexpression of glutathione-s-transferase mitigates transplant arteriosclerosis in rabbit carotid allografts.

Authors:  Ya Xu; Bin Gong; Yongzhen Yang; Yogesh C Awasthi; Paul J Boor
Journal:  Transplantation       Date:  2010-02-27       Impact factor: 4.939

4.  Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice.

Authors:  Xue Gao; Souad Belmadani; Andrea Picchi; Xiangbin Xu; Barry J Potter; Neera Tewari-Singh; Stefano Capobianco; William M Chilian; Cuihua Zhang
Journal:  Circulation       Date:  2007-01-02       Impact factor: 29.690

5.  Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation.

Authors:  Verena Pihusch; Markus Pihusch; Marius Penovici; Hans J Kolb; Erhard Hiller; Rudolf Pihusch
Journal:  Thromb Res       Date:  2005-01-25       Impact factor: 3.944

Review 6.  Human tissue-type plasminogen activator.

Authors:  E K O Kruithof; S Dunoyer-Geindre
Journal:  Thromb Haemost       Date:  2014-04-10       Impact factor: 5.249

7.  Tissue factor activity in whole blood.

Authors:  Saulius Butenas; Beth A Bouchard; Kathleen E Brummel-Ziedins; Behnaz Parhami-Seren; Kenneth G Mann
Journal:  Blood       Date:  2004-12-16       Impact factor: 22.113

8.  MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells.

Authors:  Baoliang Guo; Ken Inoki; Motohide Isono; Hiroyuki Mori; Keizo Kanasaki; Toshiro Sugimoto; Satoshi Akiba; Takashi Sato; Baofeng Yang; Ryuichi Kikkawa; Atsunori Kashiwagi; Masakazu Haneda; Daisuke Koya
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

Review 9.  The zinc finger domain of IKKγ (NEMO) protein in health and disease.

Authors:  Amde Selassie Shifera
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310

Review 10.  Functional stability of plasminogen activator inhibitor-1.

Authors:  Songul Yasar Yildiz; Pinar Kuru; Ebru Toksoy Oner; Mehmet Agirbasli
Journal:  ScientificWorldJournal       Date:  2014-10-15
View more
  4 in total

1.  Sinapine Thiocyanate Ameliorates Vascular Endothelial Dysfunction in Hypertension by Inhibiting Activation of the NLRP3 Inflammasome.

Authors:  Yang Liu; Hong-Lin Yin; Chao Li; Feng Jiang; Shi-Jun Zhang; Xin-Rong Zhang; Yun-Lun Li
Journal:  Front Pharmacol       Date:  2021-02-09       Impact factor: 5.810

2.  Efficacy and safety of Tengfu Jiangya tablet combined with valsartan/amlodipine in the treatment of stage 2 hypertension: study protocol for a randomized controlled trial.

Authors:  Yu Wang; Zhen Hua; Wenjing Chen; Yushuo Zhu; Yunlun Li
Journal:  Trials       Date:  2022-02-22       Impact factor: 2.279

3.  Sinapine Thiocyanate Inhibits the Proliferation and Mobility of Pancreatic Cancer Cells by Up-Regulating GADD45A.

Authors:  Jingya Wang; Zhirui Zeng; Shan Lei; Junbin Han; Shanggao Liao; Jinjuan Zhang; Lu Wang; Yuhua Dong; Haiyang Li; Tengxiang Chen
Journal:  J Cancer       Date:  2022-01-24       Impact factor: 4.207

4.  Evaluation of different commercial antibodies for their ability to detect human and mouse tissue factor by western blotting.

Authors:  Axel Rosell; Bernhard Moser; Yohei Hisada; Rukesh Chinthapatla; Grace Lian; Yi Yang; Matthew J Flick; Nigel Mackman
Journal:  Res Pract Thromb Haemost       Date:  2020-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.